Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel · Delayed Price · Currency is ILS · Price in ILA 9,906.00
-93.00 (-0.93%)
Jan 22, 2026, 11:05 AM IDT
Teva Pharmaceutical Industries Employees
As of December 31, 2024, Teva Pharmaceutical Industries had 35,686 total employees, including 33,892 full-time and 1,794 part-time employees. The number of employees decreased by 786 or -2.16% compared to the previous year.
Employees
35,686
Change (1Y)
-786
Growth (1Y)
-2.16%
Revenue / Employee
1.60M ILS
Profits / Employee
67.86K ILS
Market Cap
113.77B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 35,686 | -786 | -2.16% | 33,892 | 1,794 |
| Dec 31, 2023 | 36,472 | 1,347 | 3.83% | 35,001 | 1,471 |
| Dec 31, 2022 | 35,125 | -854 | -2.37% | 34,004 | 1,121 |
| Dec 31, 2021 | 35,979 | -2,393 | -6.24% | 34,713 | 1,266 |
| Dec 31, 2020 | 38,372 | -1,667 | -4.16% | 37,100 | 1,272 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Danel (Adir Yeoshua) | 4,290 |
| Novolog (Pharm-Up 1966) | 936 |
| Kamada | 420 |
| Bait Bakfar | 227 |
| Ilex Medical | 178 |
| SofWave Medical | 126 |
| BrainsWay | 120 |
| Golden House | 116 |
Teva Pharmaceutical Industries News
- 17 hours ago - ESGD, SPOT, SE, TEVA: Large Outflows Detected at ETF - Nasdaq
- 19 hours ago - Independence Bank of Kentucky Buys 66 Shares of Teva Pharmaceutical Industries Ltd (TEVA) - GuruFocus
- 7 days ago - Teva (TEVA) Gains FDA Approval for Ajovy in Pediatric Migraine Treatment - GuruFocus
- 7 days ago - AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine - GlobeNewsWire
- 7 days ago - Teva Is No Longer A Turnaround Story, It's A Growth One - Seeking Alpha
- 8 days ago - Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 8 days ago - Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference Transcript - GuruFocus
- 8 days ago - Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha